|
|
|
|
| LEADER |
01430nam a2200253 u 4500 |
| 001 |
EB002220376 |
| 003 |
EBX01000000000000001357337 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
240703 r ||| eng |
| 100 |
1 |
|
|a Sutton, Desirée
|
| 245 |
0 |
0 |
|a One dose of doxycycline for the prevention of lyme disease
|h Elektronische Ressource
|b a review of clinical effectiveness and guidelines
|c Desirée Sutton, Carolyn Spry
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c May 21, 2019, 2019
|
| 300 |
|
|
|a 1 PDF file (31 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a Spry, Carolyn
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK545493
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The objective of this report is to summarize the evidence regarding the clinical effectiveness of one dose of doxycycline for the prevention of Lyme disease in patients with tick attachment as well as relevant evidence-based guidelines associated with the use of one dose of doxycycline for the prevention of Lyme disease in patients with tick attachment
|